ATE412407T1 - Arzneimittel zubereitung enthaltend 2-amino-2-ä2- (4-octylphenyl)ethylüpropane-1,3-diol, ein lecithin und ein saccharid - Google Patents
Arzneimittel zubereitung enthaltend 2-amino-2-ä2- (4-octylphenyl)ethylüpropane-1,3-diol, ein lecithin und ein saccharidInfo
- Publication number
- ATE412407T1 ATE412407T1 AT98905636T AT98905636T ATE412407T1 AT E412407 T1 ATE412407 T1 AT E412407T1 AT 98905636 T AT98905636 T AT 98905636T AT 98905636 T AT98905636 T AT 98905636T AT E412407 T1 ATE412407 T1 AT E412407T1
- Authority
- AT
- Austria
- Prior art keywords
- octylphenyl
- saccharide
- lecithin
- diol
- amino
- Prior art date
Links
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 title abstract 2
- 150000001720 carbohydrates Chemical class 0.000 title abstract 2
- 229940067606 lecithin Drugs 0.000 title abstract 2
- 235000010445 lecithin Nutrition 0.000 title abstract 2
- 239000000787 lecithin Substances 0.000 title abstract 2
- 208000023275 Autoimmune disease Diseases 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 238000010322 bone marrow transplantation Methods 0.000 abstract 1
- KKGQTZUTZRNORY-UHFFFAOYSA-N fingolimod Chemical compound CCCCCCCCC1=CC=C(CCC(N)(CO)CO)C=C1 KKGQTZUTZRNORY-UHFFFAOYSA-N 0.000 abstract 1
- 230000001506 immunosuppresive effect Effects 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
- 210000000056 organ Anatomy 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 230000001629 suppression Effects 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Biophysics (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Biochemistry (AREA)
- Transplantation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP4366897 | 1997-02-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE412407T1 true ATE412407T1 (de) | 2008-11-15 |
Family
ID=12670236
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT98905636T ATE412407T1 (de) | 1997-02-27 | 1998-02-25 | Arzneimittel zubereitung enthaltend 2-amino-2-ä2- (4-octylphenyl)ethylüpropane-1,3-diol, ein lecithin und ein saccharid |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US6277888B1 (de) |
| EP (2) | EP0990440B1 (de) |
| JP (1) | JP4153563B2 (de) |
| KR (1) | KR20000075745A (de) |
| CN (1) | CN1178653C (de) |
| AT (1) | ATE412407T1 (de) |
| AU (1) | AU735406B2 (de) |
| BR (1) | BR9811453A (de) |
| CA (1) | CA2282378C (de) |
| DE (1) | DE69840169D1 (de) |
| DK (1) | DK0990440T3 (de) |
| ES (1) | ES2317663T3 (de) |
| IL (1) | IL131608A (de) |
| NZ (1) | NZ337823A (de) |
| PT (1) | PT990440E (de) |
| RU (1) | RU2188004C2 (de) |
| SI (1) | SI0990440T1 (de) |
| WO (1) | WO1998037875A1 (de) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9624038D0 (en) * | 1996-11-19 | 1997-01-08 | Sandoz Ltd | Organic compounds |
| JP4627356B2 (ja) * | 1999-06-30 | 2011-02-09 | 昭 松森 | ウイルス性心筋炎の予防または治療薬剤 |
| EP1315735A4 (de) | 2000-08-31 | 2005-04-06 | Merck & Co Inc | Phosphat-derivate als immunoregulatorische verbindungen |
| DK1471054T3 (da) * | 2002-01-11 | 2009-11-09 | Daiichi Sankyo Co Ltd | Aminoalkohol-derivat eller phosphonsyre-derivat og medicinsk sammensætning, der indeholder disse |
| PE20130200A1 (es) * | 2003-04-08 | 2013-03-09 | Novartis Ag | Composicion farmaceutica que contiene un agonista del receptor s1p y un alcohol de azucar |
| RU2233163C1 (ru) * | 2003-04-30 | 2004-07-27 | Государственное учреждение "Нижегородский научно-исследовательский кожно-венерологический институт" | Способ лечения акантолитической пузырчатки |
| GB0329498D0 (en) * | 2003-12-19 | 2004-01-28 | Novartis Ag | Organic compounds |
| NZ549162A (en) | 2004-02-24 | 2009-12-24 | Sankyo Co | Amino-pyrrol alcohol compounds |
| PL1773307T3 (pl) * | 2004-07-30 | 2015-03-31 | Novartis Ag | Preparaty 2-amino-1,3-propanodioli i ich analogów |
| KR20070085465A (ko) * | 2004-11-29 | 2007-08-27 | 노파르티스 아게 | Ｓ１ｐ 수용체 효능제의 투여 용법 |
| EP1679065A1 (de) | 2005-01-07 | 2006-07-12 | OctoPlus Sciences B.V. | Zubereitung mit kontrollierter Freisetzung von Interferon auf PEGT/PBT-Block-Copolymer-Basis |
| ES2529724T3 (es) * | 2005-09-09 | 2015-02-25 | Novartis Ag | Tratamiento de enfermedades autoinmunes |
| AU2011235934A1 (en) * | 2006-09-26 | 2011-11-03 | Novartis Ag | Pharmaceutical compositions comprising an S1P modulator |
| EP1923055A1 (de) * | 2006-09-26 | 2008-05-21 | Novartis AG | Gefriergetrocknete pharmazeutische Zusammensetzung mit einem S1P Agonisten oder Modulator |
| EP3733161A1 (de) | 2007-10-12 | 2020-11-04 | Novartis AG | Zusammensetzung mit sphingosin-1-phosphat (s1p)-rezeptormodulatoren |
| PL2278960T5 (pl) | 2008-03-17 | 2020-06-29 | Actelion Pharmaceuticals Ltd. | Schemat dawkowania dla selektywnego agonisty receptora sip1 |
| AR085749A1 (es) | 2011-04-01 | 2013-10-23 | Novartis Ag | Formulaciones |
| RU2483749C2 (ru) * | 2011-04-15 | 2013-06-10 | Леонид Леонидович Клопотенко | Фармацевтическая композиция, содержащая инсулин и липосомы, для местного применения в виде биопленки |
| RU2483748C2 (ru) * | 2011-04-15 | 2013-06-10 | Леонид Леонидович Клопотенко | Фармацевтическая композиция, содержащая инсулин и липосомы, для местного применения в виде пластыря |
| WO2013020069A1 (en) * | 2011-08-03 | 2013-02-07 | Ma Zhongmin | Treatment of type 2 diabetes with fty720 |
| EP3027174B1 (de) * | 2013-07-29 | 2019-07-24 | Aizant Drug Research Solutions Private Limited | Pharmazeutische zusammensetzungen von fingolimod |
| GR1009654B (el) | 2018-08-31 | 2019-11-18 | Φαρματεν Α.Β.Ε.Ε. | Φαρμακευτικο σκευασμα που περιλαμβανει εναν ανοσοτροποποιητικο παραγοντα και μεθοδος για την παρασκευη αυτου |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5612993B2 (de) | 1973-09-03 | 1981-03-25 | ||
| US4020159A (en) * | 1974-10-08 | 1977-04-26 | Apotheker A. Herbert K.G., Fabrik Pharmazeutischer Praparate Wiesbaden | Methods of and medications for treating cardiac disorders by using strophanthin |
| JPS5562010A (en) * | 1978-10-31 | 1980-05-10 | Ajinomoto Co Inc | Fat emulsion for intravenous injection |
| AU5078885A (en) * | 1984-12-20 | 1986-06-26 | Warner-Lambert Company | Non-irritant detergent |
| JPS61172814A (ja) * | 1985-01-25 | 1986-08-04 | Ss Pharmaceut Co Ltd | 安定な低溶血性ビタミンｅ注射液 |
| JPS63152327A (ja) | 1987-11-20 | 1988-06-24 | Toyama Chem Co Ltd | 脂肪乳剤から成る溶血防止用組成物を含有する製剤 |
| JPH01172814A (ja) | 1987-12-26 | 1989-07-07 | Canon Inc | レーザーユニット |
| AU6461090A (en) | 1989-10-30 | 1991-05-02 | Abbott Laboratories | Injectable formulation for lipophilic drugs |
| US5091188A (en) * | 1990-04-26 | 1992-02-25 | Haynes Duncan H | Phospholipid-coated microcrystals: injectable formulations of water-insoluble drugs |
| JPH04173736A (ja) * | 1990-11-06 | 1992-06-22 | Nippon Shinyaku Co Ltd | 乳化剤 |
| DE69321823T2 (de) | 1992-10-21 | 1999-06-02 | Taito Co., Ltd., Tokio/Tokyo | 2-amino-1, 3- propandiolverbindung und immunosuppressium |
| JPH06340525A (ja) | 1993-06-02 | 1994-12-13 | Lion Corp | 安定な低眼刺激性ビタミンａ類可溶化点眼剤 |
| US5683693A (en) * | 1994-04-25 | 1997-11-04 | Trustees Of Dartmouth College | Method for inducing T cell unresponsiveness to a tissue or organ graft with anti-CD40 ligand antibody or soluble CD40 |
| EP0778263B1 (de) | 1994-08-22 | 2002-01-09 | Welfide Corporation | Benzolderivate und deren medizinische verwendung |
| JP3169807B2 (ja) | 1995-09-18 | 2001-05-28 | 本田技研工業株式会社 | ロータ組み付け装置 |
| WO1997024112A1 (en) * | 1995-12-28 | 1997-07-10 | Yoshitomi Pharmaceutical Industries, Ltd. | External preparation |
| JP2002241272A (ja) * | 1996-07-18 | 2002-08-28 | Mitsubishi Pharma Corp | 医薬処方組成物 |
| KR100190826B1 (ko) * | 1996-08-26 | 1999-06-01 | 강재헌 | 적혈구 용혈 억제용 약제학적 조성물 및 그의제조방법 |
-
1998
- 1998-02-25 KR KR1019997007815A patent/KR20000075745A/ko not_active Ceased
- 1998-02-25 IL IL13160898A patent/IL131608A/xx not_active IP Right Cessation
- 1998-02-25 DE DE69840169T patent/DE69840169D1/de not_active Expired - Lifetime
- 1998-02-25 ES ES98905636T patent/ES2317663T3/es not_active Expired - Lifetime
- 1998-02-25 NZ NZ337823A patent/NZ337823A/en not_active IP Right Cessation
- 1998-02-25 CA CA002282378A patent/CA2282378C/en not_active Expired - Fee Related
- 1998-02-25 US US09/380,274 patent/US6277888B1/en not_active Expired - Lifetime
- 1998-02-25 RU RU99120398/14A patent/RU2188004C2/ru not_active IP Right Cessation
- 1998-02-25 CN CNB988045257A patent/CN1178653C/zh not_active Expired - Fee Related
- 1998-02-25 WO PCT/JP1998/000755 patent/WO1998037875A1/ja not_active Ceased
- 1998-02-25 AT AT98905636T patent/ATE412407T1/de active
- 1998-02-25 AU AU61155/98A patent/AU735406B2/en not_active Ceased
- 1998-02-25 BR BR9811453-0A patent/BR9811453A/pt not_active Application Discontinuation
- 1998-02-25 DK DK98905636T patent/DK0990440T3/da active
- 1998-02-25 JP JP53750798A patent/JP4153563B2/ja not_active Expired - Fee Related
- 1998-02-25 EP EP98905636A patent/EP0990440B1/de not_active Expired - Lifetime
- 1998-02-25 SI SI9830915T patent/SI0990440T1/sl unknown
- 1998-02-25 EP EP08162705A patent/EP2030614A1/de not_active Withdrawn
- 1998-02-25 PT PT98905636T patent/PT990440E/pt unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2282378A1 (en) | 1998-09-03 |
| EP2030614A1 (de) | 2009-03-04 |
| NZ337823A (en) | 2001-04-27 |
| PT990440E (pt) | 2009-02-05 |
| JP4153563B2 (ja) | 2008-09-24 |
| WO1998037875A1 (fr) | 1998-09-03 |
| US6277888B1 (en) | 2001-08-21 |
| DE69840169D1 (de) | 2008-12-11 |
| CA2282378C (en) | 2008-12-30 |
| KR20000075745A (ko) | 2000-12-26 |
| HK1027959A1 (en) | 2001-02-02 |
| CN1178653C (zh) | 2004-12-08 |
| DK0990440T3 (da) | 2009-02-23 |
| CN1253499A (zh) | 2000-05-17 |
| HK1027039A1 (en) | 2001-01-05 |
| IL131608A0 (en) | 2001-01-28 |
| EP0990440A4 (de) | 2004-04-21 |
| IL131608A (en) | 2003-02-12 |
| EP0990440B1 (de) | 2008-10-29 |
| AU6115598A (en) | 1998-09-18 |
| BR9811453A (pt) | 2000-09-12 |
| ES2317663T3 (es) | 2009-04-16 |
| RU2188004C2 (ru) | 2002-08-27 |
| EP0990440A1 (de) | 2000-04-05 |
| SI0990440T1 (sl) | 2009-04-30 |
| AU735406B2 (en) | 2001-07-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE412407T1 (de) | Arzneimittel zubereitung enthaltend 2-amino-2-ä2- (4-octylphenyl)ethylüpropane-1,3-diol, ein lecithin und ein saccharid | |
| PT812588E (pt) | Composicao farmaceutica externa para administracao topica contendo 2-amino-2-(2-(4-octilfenil)-etil)-propano-1,3-diol para o tratamento de doencas provocadas por uma afeccao imunitaria | |
| PT1050301E (pt) | Composições medicinais contendo 2-amino-2-[2-(4- octilfenil)etil]propano-1,3-diol | |
| DE59902055D1 (de) | Zweiteilige kapsel zur aufnahme von pharmazeutischen zubereitungen für pulverinhalatoren | |
| ES2179910T3 (es) | Modificacion cristalina del cdch, procedimiento para su preparacion y composiciones farmaceuticas que lo contienen. | |
| FI914919A7 (fi) | AIDS-potilaiden neurologisten sairauksien hoidossa tehokkaat farmaseuttiset koostumukset, jotka sisältävät vaikuttavana aineena vähintään yhtä yhdistettä, joka on valittu ryhmästä, joka käsittää S-adenosyyli -L-metioniinisuolan, 5-metyylitetrahydrofool | |
| RU99120398A (ru) | Фармацевтическая композиция | |
| FI972669A0 (fi) | Peptidin p277 analogeja ja niitä sisältäviä farmaseuttisia koostumuksia diabeteksen hoitamiseksi ja diagnosoimiseksi | |
| HUP0004375A2 (hu) | Azelainsavat tartalmazó kompozíció | |
| ITRM940570A0 (it) | "sale della l-carnitina e composizioni farmaceutiche che lo contengonoper il trattamento di affezioni cutanee" | |
| HUP0202525A2 (hu) | Mofetil mikofenolát és PEG-IFN-alfa együttes alkalmazása, valamint az azokat tartalmazó gyógyszerkészítmények és kit | |
| BR0010983A (pt) | Preparações para a aplicação de agentes antiinflamatórios | |
| ATE174798T1 (de) | Die herstellung von zusammensetzungen zur behandlung von krankheiten der zellproliferation | |
| FI982689L (fi) | 2-fenyyli-1,2-bentsoisoselenatsol-3(2H)-onin käyttö Alzheimerin taudin käsittelyyn tarkoiettujen farmaseuttisten valmisteiden valmistukseen | |
| NO172537C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive 3-desmetyl-4-fluor-mevalonsyrederivater | |
| CA2340734A1 (en) | Optically active pyridyl-4h-1,2,4-oxadiazine derivative and its use in the treatment of vascular diseases | |
| FR2456104A1 (fr) | Nouvelles pyrazinobenzodiazepines, leur preparation et leur application comme medicaments | |
| ITRM940571A0 (it) | "sale della l-carnitina e composizioni farmaceutiche che lo contengonoper il trattamento di affezioni cutanee" | |
| NO883468D0 (no) | Fremgangsmaate til fremstilling av farmasoeytiske blandinger inneholdende cyklopeptider som reserpsjonsbefordrere ved applikasjon paa slimhuden. | |
| HUP9901303A2 (hu) | Gyógyszerkészítmény autoimmun betegségek kezelésére | |
| ES2044170T3 (es) | Sal de estroncio, su procedimiento de preparacion y las composiciones farmaceuticas que la contienen. | |
| BR9810452A (pt) | Nova combinação de medicamentos contra asma | |
| WO1993017691A3 (en) | Pharmaceutical compositions containing monosialoganglioside gm1 or a derivative thereof suitable for the treatment of parkinson's disease | |
| NO168173C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 5-oxo-1-imidazolidinacetamid-derivater | |
| BR9712033A (pt) | Composição farmacêutica para tratamento de doenças virais. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 0990440 Country of ref document: EP |